These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25673253)

  • 1. Fornix triamcinolone injection for thyroid orbitopathy.
    Hamed-Azzam S; Mukari A; Feldman I; Saliba W; Jabaly-Habib H; Briscoe D
    Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):811-6. PubMed ID: 25673253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.
    Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy.
    Xu D; Liu Y; Xu H; Li H
    Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy].
    Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM
    Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335
    [No Abstract]   [Full Text] [Related]  

  • 5. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series.
    Chee E; Chee SP
    Eye (Lond); 2008 Feb; 22(2):311-5. PubMed ID: 17917686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.
    Ebner R; Devoto MH; Weil D; Bordaberry M; Mir C; Martinez H; Bonelli L; Niepomniszcze H
    Br J Ophthalmol; 2004 Nov; 88(11):1380-6. PubMed ID: 15489477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periocular methotrexate versus periocular triamcinolone injections for active thyroid-associated orbitopathy: a randomized clinical trial.
    Swaify IY; Nasr HE; El Essawy RA; Elessawy KB
    Jpn J Ophthalmol; 2023 Nov; 67(6):699-710. PubMed ID: 37540324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves' ophthalmopathy.
    Bordaberry M; Marques DL; Pereira-Lima JC; Marcon IM; Schmid H
    Acta Ophthalmol; 2009 Feb; 87(1):58-64. PubMed ID: 18937809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction.
    Joos ZP; Sullivan TJ
    Clin Exp Ophthalmol; 2017 Aug; 45(6):651-652. PubMed ID: 28248444
    [No Abstract]   [Full Text] [Related]  

  • 10. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.
    Lee JM; Lee H; Park M; Baek S
    J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.
    Byun JS; Lee JK
    Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):2001-2008. PubMed ID: 29959506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method.
    Young SM; Kim YD; Lang SS; Woo KI
    Ophthalmic Plast Reconstr Surg; 2018; 34(6):587-593. PubMed ID: 29672347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy.
    Alkawas AA; Hussein AM; Shahien EA
    Clin Exp Ophthalmol; 2010 Oct; 38(7):692-7. PubMed ID: 20497432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateral and medial upper eyelid contour abnormalities in graves orbitopathy: the influence of the degree of retraction.
    Ribeiro SF; Milbratz GH; Garcia DM; Fernandes VL; Rocha-Sousa A; Falcão-Reis FM; Cruz AA
    Ophthalmic Plast Reconstr Surg; 2013; 29(1):40-3. PubMed ID: 23247033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series.
    Nicolò M; Nasciuti F; Lai S; Ghiglione D; Borgia L; Calabria G
    Eur J Ophthalmol; 2006; 16(1):129-33. PubMed ID: 16496256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrobulbar injection of triamcinolone in thyroid associated orbitopathy.
    Poonyathalang A; Preechawat P; Charoenkul W; Tangtrakul P
    J Med Assoc Thai; 2005 Mar; 88(3):345-9. PubMed ID: 15962642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of active corticosteroid-resistant graves' orbitopathy.
    Pérez-Moreiras JV; Alvarez-López A; Gómez EC
    Ophthalmic Plast Reconstr Surg; 2014; 30(2):162-7. PubMed ID: 24503568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.
    ; Chew E; Strauber S; Beck R; Aiello LP; Antoszyk A; Bressler N; Browning D; Danis R; Fan J; Flaxel C; Friedman S; Glassman A; Kollman C; Lazarus H
    Ophthalmology; 2007 Jun; 114(6):1190-6. PubMed ID: 17544778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' orbitopathy: extraocular muscle/total orbit area ratio is positively related to the Clinical Activity Score.
    Le Moli R; Pluchino A; Muscia V; Regalbuto C; Luciani B; Squatrito S; Vigneri R
    Eur J Ophthalmol; 2012; 22(3):301-8. PubMed ID: 21786273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.